Oxadiazole derivatives as potential egfr protein kinase inhibitors: prediction of in-silico admet properties and molecular docking study
Journal: International Journal of Advanced Research (Vol.13, No. 05)Publication Date: 2025-05-20
Authors : Raghvendra Dubey Nitin Deshmukh Ayushi Patud Gourav Trivedi Prakhar Soni; Mohini Patidar;
Page : 111-122
Keywords : 1 3 4-oxadiazole Hepatocellular carcinoma Liver Cancer EGFR in-silico study.;
Abstract
Background:Hepatocellular carcinoma is strongly linked to abnormalities in the EGFR triggers pathway, which is crucial for tumor cell growth, survival, and the formation of new blood vessels.
Other Latest Articles
- PREMIERS RESULTATS SUR L AMELIORATION DES PERFORMANCES AGRO-MORPHOLOGIQUES DU MANIOC (MANIHOT ESCULENTACRANTZ) PAR LA FERTILISATION ORGANO-MINERALEDANS LA ZONE OUEST DU BURKINA FASO
- OLANZAPINE-ASSOCIATED ORAL CANDIDIASIS IN AN IMMUNOCOMPETENT PATIENT: A CASE FOR FURTHER INVESTIGATION
- Effects of Burning on Chemical Attributes And Soil Organic Matter In Cerrado Areas
- Umbilical cord coiling index as a marker of maternal and perinatal outcome: a retrospective study
- Analyse des strategies de coping chez les conducteurs professionnels de bus a Casablanca: Comparaison de la conduite pendant et hors du mois de Ramadan
Last modified: 2025-06-04 16:36:44